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Background Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) occurs in up to 1.5% of patients with-
in the first year. The development of an aorto-atrial fistula (AAF) is a rare but problematic complication of IE,
which can be confirmed with transoesophageal echocardiography (TOE). We present an exceptional case of
occluding an aorto-left atrial fistula only diagnosed with intraprocedural TOE during a subsequent procedure of
MitraClip implantation.
...................................................................................................................................................................................................
Case summary A 79-year-old symptomatic male patient with multiple comorbidities was referred due to severe mitral regurgita-
tion (MR). He has had prior TAVI which was complicated with streptococcal IE for which he had received pro-
longed antibacterial therapy. Transthoracic echocardiography (TTE) revealed severe MR. The patient was accepted
for a MitraClip procedure by the heart team. Intra-procedural TOE revealed also a significant continuous shunt
through an AAF which was likely caused by the endocarditis. The strategy was therefore defined as to occlude the
fistula with an Amplatzer Vascular Plug II 12 mm. The plug was released in the fistula leaving an insignificant residual
shunt. After the transseptal puncture one MitraClip XTR was implanted, reducing the MR to mild. After the pro-
cedure, the patient’s general clinical condition improved without signs of haemolysis. The pre-discharge TTE con-
firmed trace residual shunt, mild residual MR and mild paravalvular leakage.
...................................................................................................................................................................................................
Discussion Our case illustrates a complex transcatheter structural heart intervention with improvised procedural strategies
based on the intra-procedural TOE findings. We conclude that the pre-procedural TOE needs to be comprehen-
sive rather than exclusive, particularly in the context of bioprosthesis-related endocarditis.
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Infective endocarditis (IE) after transcatheter aortic valve implant-
ation (TAVI) occurs in up to 1.5% of patients within the first year.1
The development of an aorto-atrial fistula (AAF) is a rare but prob-
lematic complication of IE, which can be confirmed with transoeso-
phageal echocardiography (TOE).2 We present an exceptional case
of occluding an AAF diagnosed with intraprocedural TOE during a
subsequent procedure of MitraClip implantation.
Timeline
Case presentation
A 79-year-old male patient who presented progressive dyspnoea and
cardiac decompensation was presented in the heart team meeting. The
patient had been known with an extensive medical history including dia-
betes, atrial fibrillation (AF), non-Hodgkin lymphoma, and hostile chest.
He had undergone a percutaneous coronary intervention to the left an-
terior descending artery for non-ST-elevation myocardial infarction 3
years ago and a TAVI due to severe aortic valve stenosis 1.5 years ago.
Seven months after the TAVI, the patient was hospitalized in a per-
ipheral hospital due to persistent high fever including night sweating
and chills. The blood bacterial test showed instant Gram-positive and
subsequent blood culture-confirmed positive Streptococcus mitis infec-
tion. Blood culture of other suspicious Gramþ bacteria and urine cul-
ture yielded negative results. The TOE revealed a suspicious mobile
structure in the left ventricular outflow tract and 6 days later the TOE
was repeated and demonstrated tissue thickening and abscess forma-
tion around the aortic bioprosthesis with a large vegetation extending
towards the anterior mitral valve leaflet. The multidisciplinary endo-
carditis team acknowledged the indication for surgery because of the
explicit TOE findings; however, the patient was deemed inoperable
due to the hostile chest (sternum destruction from non-Hodgkin
lymphoma). Therefore, the patient received prolonged antimicrobial
therapy (6 months). At 1-year follow-up visit of TAVI, the patient
seemed fully recovered and the transthoracic echocardiography (TTE)
showed no more signs of vegetation or other destructive findings.
At the subsequent follow-up visit 8 months later, the patient pre-
sented again with progressive dyspnoea and New York Heart
Association (NYHA) Class 4, without fever, pain, or other complaints.
Besides a Grade 2 diastolic cardiac murmur, the physical examination
yielded no other significant findings. The blood culture yielded negative
results and C-reactive protein (CRP) level was not elevated. The TTE
revealed significant MR with an eccentric jet due to posterior mitral
leaflet tethering (Figure 1A–C) and enlarged mitral annulus (diameter
41 mm in the apical four-chamber view). The MR flow convergence ra-
dius was 7 mm with an effective regurgitant orifice area (EROA) of 22
mm2. The mitral inflow E-velocity was 1.3 m/s. The MR was deemed as
severe functional MR. The left ventricular ejection fraction was 55%
and the diastolic function could not be ascertained due to AF. The aor-
tic bioprosthesis appeared unremarkable with mild paravalvular leak-
age (PVL) (Figure 1D). There was also moderate tricuspid regurgitation
with a systolic pulmonary artery pressure of 49 mmHg. The subse-
quent TOE confirmed the MR aetiology and severity (with obvious
pulmonary vein systolic flow reversal). To assess the eligibility of
MitraClip implantation, the following parameters were measured: pos-
terior leaflet length (P2) 17 mm, coaptation length 3 mm, and coapta-
tion depth 4 mm. There was no significant calcification on the annulus,
leaflets, or subvalvular chordae.
Based on the symptoms, laboratory and echocardiographic results,
the possibility of endocarditis relapse was ruled out. According to the
......................................................................................................
Timeline Events
August 2018 Patient had undertaken transcatheter aortic valve
implantation (TAVI)
February 2019 Streptococcal infective endocarditis (IE) after
TAVI; prolonged antibacterial therapy was
started immediately after the diagnosis
August 2019 IE-related symptoms relieved, negative blood and
imaging tests
April 2020 Patient presented again progressive dyspnoea
without IE-related symptoms; transthoracic
echocardiography (TTE) and transoesophageal
echocardiography (TOE) showed severe func-
tional mitral regurgitation (MR) with no other
significant findings; Patients was accepted for
MitraClip implantation by the Heart Team
4 May 2020 Intra-procedural TOE showed besides severe MR,
an aorto-atrial fistula; the procedure was redir-
ected to first occlude the aorto-atrial fistula
(AAF) with an Amplatzer Vascular Plug II, after-
wards MitraClip implantation
7 May 2020 Patient was discharged with improved symptoms
without haemolysis, mild residual AAF shunt
and mild residual MR.
30 October 2020 6-month follow-up: patient presented reasonable
state: New York Heart Association Class 2, no
fever, stable vital signs without significant heart
murmur. Laboratory results yielded an
increased creatinine level (known) and C-react-
ive protein level which was suspected due to
the gout. TTE showed sustained results: mild re-
sidual MR, mild residual AAF shunt and mild-
moderate paravalvular leakage of the aortic
prosthesis.
Learning points
• Infective endocarditis after transcatheter aortic valve implantation occurs in 1.5% of patients within 1st year. Aorto-atrial fistula is a rare
life-threatening complication of infective endocarditis which can be detected accurately with transoesophageal echocardiography (TOE).
• Pre-procedural TOE needs to be comprehensive particularly in the context of bioprosthesis-related endocarditis.
































..latest recommendation of the decision pathway on management of
MR,3 this patient was deemed inoperable due to multiple comorbid-
ities and eligible for a MitraClip procedure by the multi-disciplinary
heart team based on:
• TTE findings:
• Severe MR based on TTE and TOE using the multi-parametric
approach including EROA, dominant mitral inflow E wave, and
pulmonary vein flow systolic reversal
• MR aetiology secondary to annular dilatation (presumably caused
by permanent AF) and posterior leaflet tethering (presumably
caused by the prior myocardial infarction)
• Normal mitral valve area and transmitral pressure gradient
• TOE findings:
• MR aetiology and jet location (A2-P2)
• Adequate posterior leaflet length, coaptation length and small
coaptation depth
• no significant calcification on leaflets grasping zone
Intra-procedural TOE (2 weeks after the pre-procedural TOE)
confirmed mixed aetiology of degenerative and functional MR
including posterior mitral leaflet tethering and leaflet malcoaption
(Figure 1E, F, Video 1) and anterior leaflet billowing (Videos 2 and 3).
Additionally, a significant continuous shunt through a fistula between
the aortic left coronary cusp region and left atrium was noticed
(Figure 1G, Supplementary material online, Video S1), which was
deemed a sequela of the prior endocarditis episode. The treatment
strategy was therefore modified to first occlude the fistula with an
Amplatzer Vascular Plug II (AVP II, St. Jude Medical, Abbott). A 6-Fr
Amplatz left the diagnostic catheter in combination with a 0.03500
Kimal straight wire was easily navigated through the fistula from the
sinus of Valsalva (Figure 2A). This assembly was exchanged for a 7.5-Fr
sheathLess JR4 Guiding Catheter (Asahi Intecc Co Ltd) (Figure 2C)
over a 0.03500 Safari small Guidewire (Boston Scientific) (Figure 2B). A
12 mm AVP II was released in the fistula (Figure 2D, Supplementary
material online, Video S2) leaving an insignificant residual shunt
(Figure 3A). The severe mixed (leaflet tethering, annular dilation, and
A2 billowing) MR persisted after the plug deployment. After the
transseptal puncture one MitraClip XTR (Abbott Vascular) was
implanted on the central-lateral position (Figure 4, Supplementary
material online, Video S3) reducing the MR from severe to mild
(Figure 3B) with a transmitral pressure gradient of 2 mmHg. After the
Figure 1 Pre-procedural transthoracic echocardiography showing severe eccentric mitral regurgitation (A–C) with mild paravalvular leakage of the
transcatheter aortic valve (D). Intra-procedural transoesophageal echocardiography showing severe eccentric mitral regurgitation (E, F) and a signifi-
cant continuous shunt via a fistula between the aortic root and left atrium (G).





















.procedure, the patient’s general clinical condition improved without
signs of haemolysis. The pre-discharge TTE confirmed all devices
in situ with trace residual shunt, mild residual MR and mild PVL
(Figure 5). The patient was discharged 3 days after the procedure.
During the most recent follow-up (6 months after the procedure)
the patient presented a reasonable state: NYHA Class 2, no
fever or syncope, stable vital signs without significant heart mur-
mur. There was no limb oedema but the signs of gout.
Laboratory results yielded increased creatinine and CRP levels.
The deterioration of the renal function had been identified before
the procedure and elevated CRP level was suspected due to the
gout. The TTE showed sustained results: mild residual MR, mild
residual AAF shunt and mild-moderate PVL of the aortic
prosthesis.
Discussion
Endocarditis after TAVI occurs in up to 1.5% of patients within
the first year and is strongly associated with younger age, male
sex, history of diabetes, moderate to severe PVL,1 and compro-
mised renal function.4 Approximately 50% of the patients show
transcatheter aortic bioprosthesis involvement on the TOE of
prosthesis with mitral valve involvement in 20% of cases.1,4 In
the present case, the diagnosis of prosthetic valve endocarditis
was established based on the combination of clinical manifesta-
tions, positive blood cultures and the presence of vegetation and
abscess around the aortic root by TOE examination. Per deci-
sion of the multidisciplinary Endocarditis and Valve Teams, open
heart surgery was ruled out (inoperable due to hostile chest)
Figure 2 Deployment of the Amplatzer Vascular Plug II shown with fluoroscopy. (A) An assembly of 6-Fr Amplatz left diagnostic catheter with a
0.03500 Kimal straight wire through the fistula from the sinus of Valsalva; (B) Safari small Guidewire through the fistula; (C) the 7.5-Fr sheathLess JR4
Guiding Catheter through the fistula; (D) the Amplatzer Vascular Plug II was released in the fistula (arrow).
4 B. Ren et al.
Figure 3 (A) Mild residual shunt after the Amplatzer Vascular Plug II deployment; (B) mild residual mitral regurgitation after MitraClip implantation.




















































and the patient received prolonged antibacterial therapy and was
followed up periodically by the Heart Valve Clinic where blood
tests and TTE were repeated following the European guideline
and recommendation of IE.5,6 The risk of recurrence of IE is 2–
6%7,8 and prosthetic valve endocarditis and abscess are associ-
ated with an increased rate of relapse,6 which was ruled out in
this case.
Our case illustrates a complex transcatheter structural heart inter-
vention with ad hoc procedural strategy modifications based on the
intra-procedural TOE findings of an AAF that was not noticed during
the pre-procedural TTE and TOE. Aorto-atrial fistula is a rare (1–
2%9) but life-threatening complication of IE with high rates of con-
gestive heart failure, haemodynamic instability, conduction abnormal-
ities, and mortality (>40%).10,11 In our case, the AAF was considered
a sequela of the previous IE instead of active/relapsed IE due to nega-
tive physical, laboratory and imaging findings (even though it is highly
likely that the AAF was actually overlooked during the pre-
procedural TOE). Surgery remains the preferred choice for the man-
agement of aortocavitary fistulae, yet is associated with significant
morbidity and mortality.10,12 Several cases reported successful
transcatheter closure of AAF using Amplatz plugs with promising
short-term outcomes.13–15 Naeim et al. reported transcatheter clos-
ure of AAF using two AVP II devices in a patient with active IE as a
bridge to surgery;14 For post-operative AAF after surgical aortic valve
replacement, Alkhouli et al. reported an immediate complete seal of
AAF with an ADO-II device15 and Estévez-Loureiro et al. with two
AVP III occluders.13 Potential complications associated with this ap-
proach include impingement of the valve, device embolization,
stroke, and coronary artery obstruction. Nevertheless, none of these
complications has happened in our case, nor has been reported. AAF
size and location may determine the complexity of catheter naviga-
tion and closure success. Prior computed tomography scans may
help define optimal gantry settings to identify the affected cusps. The
transcatheter aortic valve frame can serve as an important landmark
on fluoroscopy. In this case, catheter manipulations appeared rela-
tively straightforward under fluoroscopy and TOE guidance.
Conclusions
TTE can detect fistulous tracts in 50% of cases, while with TOE, the
detection rates increase to 97%.2 In our case, TOE was not only the
key in diagnosing the AAF (besides ascertaining the MR aetiology)
providing classic imaging findings but also mandatory in deciding the
size of the closure device and guiding the transcatheter closure.
When reviewed retrospectively, the fistula could have been identified
on the pre-procedural TOE. Therefore the pre-procedural TOE in-
terrogation needs to be comprehensive and exhaustive with multiple
views and acquisitions, rather than exclusive, particularly in the con-
text of bioprosthesis-related endocarditis.
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Figure 4 The Amplatzer Vascular Plug II (arrow) and MitraClip
(arrow) shown with fluoroscopy (A) and 3D transoesophageal
echocardiography (B).
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Concomitant MitraClip and plug closure of aortic-atrial fistula 7
